SCM
ORGO icon

Sterling Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Sterling Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Buy
1,394
+950
+214% +$2.32K ﹤0.01% 2809
2026
Q1 		$1.05K Hold
444
– – ﹤0.01% 3090
2025
Q4 		$2.3K Buy
444
+279
+169% +$1.35K ﹤0.01% 3049
2025
Q3 		$696 Hold
165
– – ﹤0.01% 3130
2025
Q2 		$604 Sell
165
-901
-85% -$3.36K ﹤0.01% 3132
2025
Q1 		$4.61K Sell
1,066
-1,013
-49% -$4.09K ﹤0.01% 2204
2024
Q4 		$6.65K Buy
2,079
+1,866
+876% +$6.26K ﹤0.01% 2330
2024
Q3 		$609 Buy
+213
New +$597 ﹤0.01% 2779

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sterling Capital Management's ORGO Position: Q2 2026 in Review

Sterling Capital Management increased its Organogenesis Holdings (ORGO) stake by 214% in Q2 2026, buying an estimated $2.32K and bringing the position to 1,394 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Sterling Capital Management first reported a position in ORGO in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.65K in Q4 2024. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Sterling Capital Management held 1,394 shares of Organogenesis Holdings worth $3.39K as of Q2 2026.
  • Sterling Capital Management bought 950 Organogenesis Holdings shares in Q2 2026, an estimated $2.32K.
  • Organogenesis Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2809 holding.
  • Sterling Capital Management first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Organogenesis Holdings position peaked at $6.65K in Q4 2024.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.